SnagRx vs Regenics: Compounded Semaglutide Pricing & Care

SnagRx vs Regenics compares two telehealth options for compounded GLP-1 therapy. Quick verdict: SnagRx is aimed at cost-driven patients who want predictable, locked pricing across titration on a 12-month plan; Regenics is structured for patients who want nurse-practitioner oversight and an optional Sermorelin peptide add-on.

See SnagRx pricing and plan details

Key differences at a glance: pricing, clinical model, and extras

This comparison focuses on the most distinctive supported differences: 1) pricing structure, 2) clinical oversight and staffing, 3) ancillary offerings and pharmacy notes, and 4) renewal and promotional terms. Each point below compares SnagRx and Regenics directly, using only supplied facts.

1. Pricing structure and commitments

SnagRx advertises compounded semaglutide from $69/month and tirzepatide from $119/month on a 12-month plan; month-to-month pricing is $99 and $149. The $69 and $119 figures are explicitly the 12-month plan rates and SnagRx states the rate is locked flat at every dose for the life of treatment. Regenics lists semaglutide starting at $139 for the first month and tirzepatide at $189 for the first month, with renewals at $199 and $279 unless otherwise stated. Regenics promotional pricing applies to the first month only.

2. Clinical oversight and review timing

SnagRx delivers medical care through OpenLoop Health, a network of US-licensed clinicians; SnagRx states clinician review typically within 5 hours and always within 24, with OpenLoop clinicians retaining the decision to prescribe. Regenics offers licensed nurse practitioners who review intake before prescribing and states treatment is available only when a licensed clinician determines it is medically appropriate. Both providers emphasize clinician review before a prescription is issued.

Review Regenics first-month offers

3. Pharmacy, shipping, and regulatory notes

SnagRx names its four US 503A partner pharmacies and states next-day UPS/FedEx delivery in temperature-controlled packaging; it also states LegitScript certification and that compounded medications are not FDA-approved finished products. Regenics states medication is compounded by licensed U.S. pharmacies, ships free to your door, and that compounded medications are not FDA-approved finished products. Regenics also states its pharmacy network is LegitScript certified.

4. Ancillary services and guarantees

SnagRx explicitly states no coaching or nutrition programming is provided, but it advertises a full refund if a prescription is declined and a 6-month weight-loss guarantee with terms. Regenics highlights an add-on: Sermorelin peptide therapy for recovery, energy, and muscle support, and notes FSA/HSA eligibility. SnagRx does not offer Sermorelin in the provided evidence.

Comparison table: SnagRx vs Regenics

Criterion	SnagRx	Regenics
Starting semaglutide price	From $69/mo on 12-month plan; $99/mo month-to-month	$139 first month; renews $199/mo
Tirzepatide price	$119/mo on 12-month plan; $149/mo month-to-month	$189 first month; renews $279/mo
Price changes during titration	Price locked flat at every dose for life of treatment	Promotional first month; renewal prices higher
Clinical model	OpenLoop Health network of US-licensed clinicians; review typically within 5 hours	Licensed nurse practitioners review intake before prescription
Pharmacy and shipping	Named US 503A pharmacies; next-day UPS/FedEx delivery; LegitScript stated	Compounded in USA; free shipping; LegitScript certified pharmacy network
Ancillary offerings	No coaching or nutrition programming; outcome guarantee noted	Sermorelin peptide therapy available; FSA/HSA eligible

What to expect during sign-up and fulfillment

SnagRx says the intake takes about five minutes, an OpenLoop clinician typically reviews within five hours, and approved orders ship next-day with a full refund if a prescription is declined. Regenics indicates nurse practitioners review intake before anything is prescribed and that promotional pricing applies to the first month; captured landing-page evidence for other fulfillment details was not readable in the provided source.

Start SnagRx enrollment

Safety and regulatory context

Both providers state that compounded medications are not FDA-approved finished products and are not reviewed by FDA for safety, effectiveness, or quality. SnagRx additionally encourages prospective users to speak with their provider about the specific risks and benefits of compounded medication and states its compounded medications are produced in FDA-regulated facilities but are not FDA-approved finished products. Regenics also states a licensed healthcare provider determines whether treatment is clinically appropriate.

Compare Regenics clinical options

Conclusion: SnagRx vs Regenics

SnagRx vs Regenics resolves to a tradeoff between locked, bottom-of-market annual pricing and promotional entry pricing with clinical differences. SnagRx is the lower-cost option on the annual plan and locks rate at every dose; Regenics offers nurse-practitioner-led care and an optional Sermorelin peptide line with first-month promotional pricing that renews higher.

Choose SnagRx if you want predictable, locked pricing across titration and named US 503A pharmacies with next-day shipping.

Choose Regenics if you value nurse-practitioner oversight and the availability of Sermorelin peptide therapy, and accept promotional first-month pricing that renews higher.

Go to SnagRx to review plans